fda warning compounding semaglutide october 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 FDA Drug Recalls and Warnings:

Without them, affordability challenges may persist for many patients

Abstract The glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell types within the human body

If your metabolic markers remain stable on a lower dose, that supports tapering

Retatrutide dosing schedule The retatrutide dosing protocol from clinical trials follows a similar but slightly different titration pattern: Week 1-4: 1-2 mg once weekly (starting dose varies by protocol) Week 5-8: 4 mg once weekly Week 9-12: 8 mg once weekly Week 13+: 12 mg once weekly (maximum dose) The dose increases are larger and less granular than Mounjaro

& Barnabe, C

Diarrhea affected 33% to 35% of participants